Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Veterinary CRO And CDMO Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The veterinary CRO and CDMO sector has experienced substantial expansion over the past few years. It is projected to increase from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historical growth can be linked to factors such as veterinary firms’ constrained internal research and development capacities, an expanding companion animal population, an increase in animal disease occurrences, the prompt uptake of CDMO services in advanced economies, and the need for novel veterinary biologics and pharmaceuticals.
The veterinary CRO and CDMO market is projected to experience robust expansion over the coming years. It is anticipated to reach $11.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This growth during the forecast period stems from factors such as a heightened demand for contract research and manufacturing services, advancements in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, a broadening of global regulatory compliance needs, and the increasing embrace of precision medicine for animals. Key trends expected during this period involve greater outsourcing of veterinary drug development, an increase in preclinical and clinical trial offerings, a rising need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and an enhanced emphasis on post-marketing surveillance and pharmacovigilance.
Get A Free Sample Report With In-Depth Market Insights:
Veterinary CRO And CDMO Market Demand Drivers: What’s Powering Industry Growth?
The future expansion of the veterinary CRO and CDMO market is anticipated to be fueled by an increase in pet ownership. Pet ownership refers to the status of an individual or household undertaking principal responsibility for a domesticated animal’s care, welfare, and management, which entails a lasting, lawful, and moral obligation. The rise in pet ownership is attributed to heightened understanding of the emotional and health advantages that pets offer, as individuals increasingly look for companionship, reduced stress, and better overall well-being through caring for pets. The veterinary CRO and CDMO market facilitates this growing pet ownership, with the expanding pet population stimulating the need for developing and producing veterinary drugs, vaccines, and therapies to guarantee the health and safety of animals. An example illustrates this: in March 2025, data from the American Pet Products Association, a US-based non-profit association, revealed that ninety-four (94) million U.S. households possess at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the continued rise in pet ownership is projected to propel the veterinary CRO and CDMO market moving forward.
Veterinary CRO And CDMO Market Breakdown By Product Type And Application
The veterinary cro and cdmo market covered in this report is segmented –
1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications
Subsegments:
1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance
5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance
Veterinary CRO And CDMO Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading enterprises within the veterinary CRO and CDMO market are concentrating on creating novel offerings, notably integrated multi-site CDMO networks. These networks incorporate sophisticated sterile manufacturing, lyophilization, and specific dosage capabilities, aiming to simplify drug development processes and expedite compliant routes to market. Integrated multi-site CDMO networks represent cohesive systems that bring together numerous production sites and specialized technologies, such as sterile multidose systems, lyophilization, and adaptable packaging, all managed under uniform operational and quality standards to provide comprehensive pharmaceutical development and manufacturing solutions. An illustration of this trend occurred in April 2025, when Meribel Pharma Solutions, a UK-based CDMO providing extensive services including drug development, formulation, analytical support, sterile and semi-solid manufacturing, and packaging, commenced operations. This involved a network of 13 facilities spread across France, Spain, and Sweden, designed to support products from initial development to commercial-scale production, with particular expertise in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health applications.
Veterinary CRO And CDMO Market Top Companies Driving Competitive Growth
Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.
View The Full Veterinary CRO And CDMO Market Report:
Veterinary CRO And CDMO Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
